10-K: Trulieve Cannabis Corp. Reports Full Year 2024 Results, Highlights Strategic Growth and Financial Performance
Annual Results
Trulieve Cannabis Corp. reports a 5.1% increase in revenue for 2024, driven by retail and wholesale growth, alongside improved gross profit margins.
Summary
- Trulieve Cannabis Corp. released its financial results for the year ended December 31, 2024.
- The company reported revenue of $1.186 billion, a 5.1% increase compared to $1.129 billion in 2023.
- This growth was primarily fueled by a $45.3 million increase in retail revenue and a $12.0 million increase in wholesale and other revenue.
- The company operated 225 dispensaries as of December 31, 2024, compared to 192 as of December 31, 2023.
- Cost of goods sold decreased by 12.9% to $470.7 million, improving gross profit margins.
- Gross profit increased by 21.6% to $715.7 million, with gross profit margin at 60.3% compared to 52.1% in the previous year.
- The company reported a net loss from continuing operations of $154.8 million.
- Adjusted EBITDA increased by 30.4% to $420.2 million, representing 35.4% of revenue.
- The company's cash and cash equivalents totaled $238.8 million as of December 31, 2024, with an additional $60.4 million in short-term investments.
- Net cash provided by operating activities was $271.5 million for the year ended December 31, 2024.
Sentiment
Score: 6
Explanation: The document presents a mixed sentiment. While revenue and EBITDA show positive growth, the net loss and regulatory risks temper the overall outlook. The company is growing but faces significant challenges.
Positives
- Revenue increased by 5.1% year-over-year.
- Gross profit margin significantly improved, indicating better operational efficiency.
- Adjusted EBITDA increased, showcasing improved profitability.
- Net cash provided by operating activities increased, demonstrating strong cash generation.
- The company expanded its retail footprint, increasing the number of dispensaries.
Negatives
- The company reported a net loss from continuing operations of $154.8 million.
- General and administrative expenses increased significantly due to legislative campaign contributions.
- The company is subject to Section 280E of the U.S. Internal Revenue Code, which limits deductions.
Risks
- Cannabis remains illegal under U.S. federal law, posing a risk to the company's operations.
- The regulation of cannabis in the United States is uncertain and subject to change.
- The company faces intense competition in the cannabis industry.
- The company is subject to agricultural and environmental risks related to cannabis cultivation.
- The company may face product liability claims related to the use of its products.
- The company is subject to security risks related to its products and information technology systems.
Future Outlook
The company aims to be the brand of choice for medical and adult-use customers in all of the markets that it serves and is passionate about expanding access to regulated cannabis products through advocacy, education and expansion of its distribution network.
Industry Context
The report highlights Trulieve's position as the largest cannabis retailer in the United States, operating in a highly regulated and competitive market. The company's performance is influenced by evolving state regulations, increasing competition, and the potential for federal policy changes.
Comparison to Industry Standards
- The report does not provide a direct comparison to industry standards.
- However, it mentions multi-state operators like Cresco Labs Inc., Curaleaf Holdings Inc., Green Thumb Industries Inc., and Verano Holdings Corp. as comparable companies.
- The stock performance graph compares Trulieve's cumulative total shareholder return to the Russell 2000 Index and a selected peer group.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President | NA | Jason Pernell | 2025-02-26 | Appointment |
Legal Proceedings
- There are no actual or, to our knowledge, contemplated legal proceedings material to Trulieve or in which any of our property is the subject matter.
Related Party Transactions
- The Company leases a cultivation facility and corporate office facility from an entity that is indirectly owned by the Company's Chief Executive Officer and Chair of the board of directors, a former member of the Company's board of directors, and a member of the Company's board of directors.
Stakeholder Impact
- Shareholders: The report provides information relevant to assessing the company's financial health and future prospects.
- Employees: The company is committed to hiring talented individuals and maximizing individual potential, while fostering growth and career advancement.
- Customers: The company is committed to delivering exceptional customer experiences through elevated service and high-quality branded products.
- Creditors: The report provides information relevant to assessing the company's ability to meet its debt obligations.
Next Steps
- The company will continue to invest in customer experience, product innovation, scaled production, marketing and branding, and distribution network expansion.
- The company will continue to monitor developments in the fast-paced cannabis industry and adjacent industries to help us remain competitive.
Key Dates
| Date | Description |
|---|---|
| 1940-09-17 | Trulieve Cannabis Corp. (formerly Schyan Exploration Inc.) was incorporated under the Business Corporations Act (Ontario). |
| 2000 | Colorado legalized medical marijuana via Amendment 20 to the Colorado Constitution. |
| 2010 | Arizona legalized medical cannabis in 2010 through Proposition 203, the Arizona Medical Cannabis Act. |
| 2012 | Connecticut legalized medical cannabis in 2012. |
| 2012 | Colorado legalized adult-use cannabis via the passage of Amendment 64. |
| 2013 | Maryland legalized medical cannabis in 2013. |
| 2014-02 | FinCEN issued guidance with respect to financial institutions providing banking services to cannabis businesses. |
| 2016 | Ohio legalized medical cannabis in 2016 via House Bill 523. |
| 2016-04-17 | Act 16, otherwise known as the Medical Cannabis Act, was signed into law, establishing the Pennsylvania medical cannabis program. |
| 2017 | West Virginias medical cannabis program, the West Virginia Medical Cannabis Act, was signed into law in 2017. |
| 2017-12-01 | Maryland's state-regulated medical cannabis program became operational. |
| 2018-09-19 | Schyan Exploration Inc. / Exploration Schyan Inc. filed Articles of Amendment under the Business Corporations Act (Ontario) to effect the name change from Schyan Exploration Inc. / Exploration Schyan Inc. to Trulieve Cannabis Corp. |
| 2018-09-21 | Trulieve Cannabis Corp. completed the Transaction and acquired all of the securities of Trulieve US by way of a plan of merger. |
| 2018-09-25 | The Subordinate Voting Shares commenced trading on the CSE under the symbol TRUL. |
| 2020 | Arizona legalized adult-use in 2020 through Proposition 207, known as the Smart and Safe Arizona Act. |
| 2021-01-21 | Joseph R. Biden, Jr. was sworn in as the 46th President of the United States. |
| 2021-06 | Connecticut legalized adult-use cannabis in June 2021 with the passage of Public Act 21-1 (SB 1201). |
| 2021-10-06 | The Company closed its private placement of 8% Senior Secured Notes (the '2026 Notes Tranche One') for aggregate gross proceeds of $350.0 million. |
| 2022-01-28 | The Company closed on a second tranche private placement of 8% Senior Secured Notes (the '2026 Notes Tranche Two') for aggregate gross proceeds of $76.9 million. |
| 2022-02-14 | The Company acquired a cultivation operation from CP4 Group, LLC, in Phoenix, Arizona. |
| 2022-04-26 | The Company acquired 100% of the membership interests of Greenhouse Wellness WV Dispensaries, LLC. |
| 2022-07 | The Company exited operations in Nevada. |
| 2022-10 | The Biden Administration announced its intention to review the regulation of cannabis under the CSA. |
| 2022-11-08 | Maryland voters approved a statewide referendum which legalized cannabis for adults 21 years or older, effective July 2023. |
| 2022-12-22 | The Company acquired 100% of the membership interests of Formula 420 Cannabis LLC. |
| 2023-01 | Sales began in Connecticut after the state announced that existing medical operators licensed as hybrid retailers could open for adult-use sales. |
| 2023-06 | The Company exited operations in Massachusetts. |
| 2023-07 | Maryland legalized cannabis for adults 21 years or older, effective July 2023. |
| 2023-08 | The Food and Drug Administration ('FDA') within the HHS recommended to the DEA that marijuana be rescheduled from Schedule I to Schedule III under the CSA. |
| 2023-09 | The Senate Banking Committee voted to pass the SAFER Banking Act by a bipartisan majority of 14-9. |
| 2023 | Ohio voters legalized adult-use cannabis in 2023. |
| 2023-11-27 | The DEA intervened by issuing a warning letter, advising that neither cannabis nor THC can be lawfully dispensed by a DEA-registered pharmacy. |
| 2024-05-16 | The DEA issued its Notice of Proposed Rulemaking (NPRM) to reclassify marijuana to Schedule III. |
| 2024-07-23 | The DCC issued 10 dual-use cultivation and processing certificates of operation allowing existing medical operators to cultivate and produce products for the adult-use market. |
| 2024-08-06 | The DCC issued dual-use certificates of operation to 98 eligible dispensaries across the state, a month ahead of the required deadline. |
| 2024-09 | At least one pharmacy had resumed selling low-THC oil in defiance of the DEAs warning. |
| 2024-11-01 | Adult-use home delivery is allowed in Arizona. |
| 2024-11-05 | 55.9% of Florida voters voted in favor of Florida Amendment 3 (Florida Marijuana Legalization Initiative #22-05), an adult-use cannabis legalization ballot initiative sponsored by the political action committee Smart & Safe Florida. |
| 2025-01-14 | Smart & Safe Florida filed a new initiative petition to place a constitutional amendment to legalize cannabis for adult-use on Floridas November 2026 ballot. |
| 2025-01-20 | President Donald J. Trump was sworn in as the 47th President of the United States. |
| 2025-02-26 | The Board of Directors of the Company appointed Jason Pernell as President of the Company. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.